Imperva, Inc. provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company operates in the segment of development, marketing, sales, service and support of cyber-security solutions that protect business critical data and applications whether in the cloud or on premises. Its products include its Imperva SecureSphere platform for enterprise data centers, and Imperva Incapsula and Imperva Skyfence offerings for cloud-based security services. Its Imperva SecureSphere platform provides database, file and Web application security across various physical and virtual systems in data centers. Its Imperva Incapsula product line provides cloud-based Website security, denial of service protection and performance solutions. Its Imperva Skyfence product line provides visibility into, and control over, cloud and Software-as-a-Service (SaaS) applications, including shadow information technology (IT).
Industry, Sector and Symbol:
- Sector: Computer and Technology
- Industry: Application Software
- Sub-Industry: Systems Software
- Exchange: NYSE
- Symbol: IMPV
- CUSIP: 45321L10
- Previous Close: $45.70
- 50 Day Moving Average: $41.59
- 200 Day Moving Average: $42.76
- 52-Week Range: $31.11 - $57.24
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 78.79
- P/E Growth: 7.99
- Market Cap: $1.50B
- Outstanding Shares: 32,743,000
- Beta: 2.23
- Net Margins: -25.60%
- Return on Equity: -28.37%
- Return on Assets: -16.93%
Companies Related to Imperva:
- Current Ratio: 2.56%
- Quick Ratio: 2.55%
What is Imperva's stock symbol?
Imperva trades on the New York Stock Exchange (NYSE) under the ticker symbol "IMPV."
Where is Imperva's stock going? Where will Imperva's stock price be in 2017?
16 brokerages have issued 1-year price objectives for Imperva's shares. Their forecasts range from $30.00 to $56.00. On average, they expect Imperva's share price to reach $47.62 in the next year.
When will Imperva announce their earnings?
Imperva is scheduled to release their next quarterly earnings announcement on Wednesday, May, 3rd 2017.
Who owns Imperva stock?
Imperva's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Eton Park Capital Management L.P. (2.02%), Alpine Associates Management Inc. (1.74%), Oxford Asset Management (1.68%), State Street Corp (1.58%), Artemis Investment Management LLP (1.42%) and Cortina Asset Management LLC (1.20%). Company insiders that own Imperva stock include Albert A Pimentel, Amichai Shulman, Anthony J Bettencourt, Mark E Kraynak, Shlomo Kramer, Terrence J Schmid and Tram T Phi.
Who sold Imperva stock? Who is selling Imperva stock?
Imperva's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Eton Park Capital Management L.P., American National Insurance Co. TX, Allianz Asset Management AG, Two Sigma Investments LP and Guggenheim Capital LLC. Company insiders that have sold Imperva stock in the last year include Amichai Shulman, Anthony J Bettencourt, Mark E Kraynak, Shlomo Kramer and Terrence J Schmid.
Who bought Imperva stock? Who is buying Imperva stock?
Imperva's stock was purchased by a variety of institutional investors in the last quarter, including Alpine Associates Management Inc., Alyeska Investment Group L.P., FIL Ltd, Cortina Asset Management LLC, Artemis Investment Management LLP, Oxford Asset Management, AidennLair Capital Management LP and North Run Capital LP.
How do I buy Imperva stock?
Shares of Imperva can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Imperva stock cost?
One share of Imperva stock can currently be purchased for approximately $45.70.